MID-VOLUME · HOSP-MID
ziprasidone Side Effects
ziprasidone (also sold as Geodon) sits MID-VOLUME #254 of 524 by FAERS report count. Lead signal: HOSP-MID - 24.2% mention hospitalization (4,189 reports). Demographics and serious-outcome tables follow.
Data updated 2026-05-15
- 17,328
- FAERS reports
FDA Adverse Event Reporting System extract for ziprasidone. Stamp set WATCHLIST · DEATH-HEAVY · HOSP-MID. How figures are compiled.
ziprasidone: 24.2% mention hospitalization (4,189 reports). Death stamp DEATH-HEAVY; volume band MID-VOLUME #254 of 524 by FAERS report count.
Mid-book FAERS page for ziprasidone (Geodon) (17,328 reports). Signature HOSP-MID. Dominant age band on file: 18-44. Educational reference only.
Counts from the openFDA FAERS extract (2004–2025). Stamps WATCHLIST · DEATH-HEAVY · HOSP-MID · SEX-BALANCED.
WEIGHT INCREASED leads 1,176 of 17,328 reports
Who reports · age peak 18-44 (SEX-BALANCED)
Sex coding · SEX-BALANCED
Age peak 18-44 (4,204 reports)
Reporting taper since 2004 peak
Reactions in Death Reports
Death-mentioned subset is HEAVY here (1,171 reports, 6.8%). Top co-reported reactions in that subset - voluntary, not causal.
| Reaction | Reports |
|---|---|
| COMPLETED SUICIDE | 379 |
| DEATH | 247 |
| TOXICITY TO VARIOUS AGENTS | 152 |
| CARDIAC ARREST | 101 |
| CARDIO-RESPIRATORY ARREST | 97 |
| RESPIRATORY ARREST | 56 |
| MYOCARDIAL INFARCTION | 34 |
| SUDDEN DEATH | 34 |
| ARRHYTHMIA | 33 |
| HYPOTENSION | 32 |
| OVERDOSE | 30 |
| NEUROLEPTIC MALIGNANT SYNDROME | 28 |
| ADVERSE DRUG REACTION | 27 |
| COMA | 27 |
| BLOOD GLUCOSE INCREASED | 26 |
| CONDITION AGGRAVATED | 26 |
| RESPIRATORY FAILURE | 26 |
| PNEUMONIA ASPIRATION | 25 |
| RENAL FAILURE | 25 |
Reactions in Hospitalization Reports
Hospitalization mid-share (4,189, 24.2%). Co-reported reactions:
| Reaction | Reports |
|---|---|
| WEIGHT INCREASED | 367 |
| DIABETES MELLITUS | 321 |
| DEPRESSION | 299 |
| SUICIDE ATTEMPT | 277 |
| ANXIETY | 271 |
| TYPE 2 DIABETES MELLITUS | 254 |
| SUICIDAL IDEATION | 247 |
| NEUROLEPTIC MALIGNANT SYNDROME | 244 |
| HYPERTENSION | 226 |
| DIZZINESS | 200 |
| FATIGUE | 200 |
| INSOMNIA | 197 |
| NAUSEA | 197 |
| PSYCHOTIC DISORDER | 191 |
| DYSPNOEA | 183 |
| OBESITY | 179 |
| TOXICITY TO VARIOUS AGENTS | 178 |
| HEADACHE | 174 |
| OVERDOSE | 173 |
How to read ziprasidone FAERS figures (WATCHLIST · DEATH-HEAVY · HOSP-MID)
FAERS holds 17,328 voluntary reports linked to ziprasidone (Geodon), 2004-2025. Death is listed on 1,171 (6.8%). Hospitalization appears on 4,189 (24.2%). Top co-reported indication: Bipolar Disorder.
Mid-volume extract - treat DEATH-HEAVY · HOSP-MID as signal-detection rates next to 24.2% mention hospitalization (4,189 reports).
Read with ziprasidone
Peers ranked by ABS(total_reports), then an ABS(death_share) pole; guide hop follows DEATH-HEAVY · HOSP-MID stamps.
ABS(total_reports) peer at 17,378 FAERS cases (Δ 50 heavier vs ziprasidone); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-MID · SEX-BALANCED.
ABS(total_reports) peer at 17,199 FAERS cases (Δ 129 lighter vs ziprasidone); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-MID · SEX-BALANCED.
ABS(total_reports) peer at 17,186 FAERS cases (Δ 142 lighter vs ziprasidone); DEATH-MARKED · HOSP-HEAVY · SEX-BALANCED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-MID · SEX-BALANCED.
ABS(total_reports) peer at 17,512 FAERS cases (Δ 184 heavier vs ziprasidone); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-MID · SEX-BALANCED.
ABS(death_share) pole at 62.1% death-mentioned reports (Δ 55.3 pp vs ziprasidone's DEATH-HEAVY): CASELOAD · HOSP-MID.
ziprasidone stamps DEATH-HEAVY · HOSP-MID; FAERS outcome shares are signal-detection rates, not incidence. Read them next to caseload WATCHLIST and the label guide.